These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 22678731

  • 1. Amino acid substitutions in the Candida albicans sterol Δ5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence.
    Morio F, Pagniez F, Lacroix C, Miegeville M, Le Pape P.
    J Antimicrob Chemother; 2012 Sep; 67(9):2131-8. PubMed ID: 22678731
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Identification and characterization of four azole-resistant erg3 mutants of Candida albicans.
    Martel CM, Parker JE, Bader O, Weig M, Gross U, Warrilow AG, Rolley N, Kelly DE, Kelly SL.
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4527-33. PubMed ID: 20733039
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Azole resistance by loss of function of the sterol Δ⁵,⁶-desaturase gene (ERG3) in Candida albicans does not necessarily decrease virulence.
    Vale-Silva LA, Coste AT, Ischer F, Parker JE, Kelly SL, Pinto E, Sanglard D.
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1960-8. PubMed ID: 22252807
    [Abstract] [Full Text] [Related]

  • 7. Fluconazole treatment is effective against a Candida albicans erg3/erg3 mutant in vivo despite in vitro resistance.
    Miyazaki T, Miyazaki Y, Izumikawa K, Kakeya H, Miyakoshi S, Bennett JE, Kohno S.
    Antimicrob Agents Chemother; 2006 Feb; 50(2):580-6. PubMed ID: 16436713
    [Abstract] [Full Text] [Related]

  • 8. The amino acid substitution N136Y in Candida albicans sterol 14alpha-demethylase is involved in fluconazole resistance.
    Alvarez-Rueda N, Fleury A, Logé C, Pagniez F, Robert E, Morio F, Le Pape P.
    Med Mycol; 2016 Oct 01; 54(7):764-775. PubMed ID: 27143634
    [Abstract] [Full Text] [Related]

  • 9. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
    Eddouzi J, Parker JE, Vale-Silva LA, Coste A, Ischer F, Kelly S, Manai M, Sanglard D.
    Antimicrob Agents Chemother; 2013 Jul 01; 57(7):3182-93. PubMed ID: 23629718
    [Abstract] [Full Text] [Related]

  • 10. Loss of C-5 Sterol Desaturase Activity in Candida albicans: Azole Resistance or Merely Trailing Growth?
    Luna-Tapia A, Butts A, Palmer GE.
    Antimicrob Agents Chemother; 2019 Jan 01; 63(1):. PubMed ID: 30323044
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations.
    Jensen RH, Astvad KM, Silva LV, Sanglard D, Jørgensen R, Nielsen KF, Mathiasen EG, Doroudian G, Perlin DS, Arendrup MC.
    J Antimicrob Chemother; 2015 Sep 01; 70(9):2551-5. PubMed ID: 26017038
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis.
    Cernicka J, Subik J.
    Int J Antimicrob Agents; 2006 May 01; 27(5):403-8. PubMed ID: 16621465
    [Abstract] [Full Text] [Related]

  • 16. Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature.
    Morio F, Loge C, Besse B, Hennequin C, Le Pape P.
    Diagn Microbiol Infect Dis; 2010 Apr 01; 66(4):373-84. PubMed ID: 20226328
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans.
    Feng W, Yang J, Xi Z, Qiao Z, Lv Y, Wang Y, Ma Y, Wang Y, Cen W.
    Microb Drug Resist; 2017 Jul 01; 23(5):563-570. PubMed ID: 27976986
    [Abstract] [Full Text] [Related]

  • 20. Triazole Evolution of Candida parapsilosis Results in Cross-Resistance to Other Antifungal Drugs, Influences Stress Responses, and Alters Virulence in an Antifungal Drug-Dependent Manner.
    Papp C, Bohner F, Kocsis K, Varga M, Szekeres A, Bodai L, Willis JR, Gabaldón T, Tóth R, Nosanchuk JD, Vágvölgyi C, Gácser A.
    mSphere; 2020 Oct 28; 5(5):. PubMed ID: 33115837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.